HuagongsheHuagongshe Chemistry Print Report · For research reference only
1,8-Diazabicyclo(5.4.0)undec-7-ene → [2-(1H-Benzimidazol-2-ylsulfanylmethyl)-3-chloro-pyridin-4-yl]methyl-[2-(3-nitroimidazo[1,2-b]pyridazin-6-ylsulfanyl)ethyl]amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | [2-(1H-benzimidazol-2-ylsulfanylmethyl)-3-chloropyridin-4-yl]-(2-chloroethyl)methyl-amine | HCID 53762852 | — |
| Reactant | HCID 178526776 | HCID 178526776 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | [2-(1H-Benzimidazol-2-ylsulfanylmethyl)-3-chloro-pyridin-4-yl]methyl-[2-(3-nitroimidazo[1,2-b]pyridazin-6-ylsulfanyl)ethyl]amine | HCID 70272959 | 66.4% |
Reaction Steps
0.44 g (1.0 mmol) of [2-(1H-benzimidazol-2-ylsulfanylmethyl)-3-chloropyridin-4-yl]-(2-chloroethyl)methyl-amine, 0.24 g (1.2 mmol) of 3-nitroimidazo[1,2-b]pyridazine-6-thiol and 0.52 ml (3.5 mmol) of DBU are reacted in 10 ml of dimethylformamide by the procedure described in Example 16. After crystallization from diisopropyl ether, 0.35 g (66%) of the title compound is obtained as a pale beige solid. M.p. 184-185° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06043242 |
| Source dataset | uspto-grants-2000_03 |
| ORD ID | ord-f94b071998c5424a8558987538b87889 |
| Source note | uspto-grants-2000_03 |